BioVaxys Technology Corp.
BVAXF
$0.0389
$0.00010.26%
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -866.50K | -399.70K | 383.70K | -2.70M | -2.12M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 944.10K | 8.10K | -635.50K | 1.70M | 1.59M |
| Change in Net Operating Assets | -378.70K | 69.70K | 253.50K | 996.30K | 509.80K |
| Cash from Operations | -301.00K | -322.00K | 1.80K | -1.50K | -17.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -778.50K | -- | -- | -- |
| Cash from Investing | 0.00 | -778.50K | -- | -- | -- |
| Total Debt Issued | 13.80K | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -33.40K | -- | -- | -- |
| Issuance of Common Stock | 729.60K | 721.40K | 962.70K | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 542.90K | 507.00K | 713.00K | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -100.00 | 0.00 | -700.00 | 1.90K | -3.20K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | 0.00 | -- |
| Net Change in Cash | 241.80K | -593.50K | 714.10K | 400.00 | -21.00K |
